13F-NT filed by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. filed this 13F-NT for the quarter ended 2022-03-31, filed 2022-05-11.
- Accession
- 0001104659-22-058624
- Filer
- CIK 1615258
- Filed
- 2022-05-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2022
A notice, 13F file number 028-18303. A notice: the holdings are in another manager's report. The resolved quarter.
Other managers
- reports for this filerFosun International Ltd028-15992
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-NT 0001104659-22-058624 | this filing | 2022-05-11 | acceptance time not in the bulk data set |